Istanbul, Turkey
Istanbul, Turkey

Istanbul University is a prominent Turkish university located in Istanbul. The main campus is adjacent to Beyazıt Square in the Fatih district, on the European side of the city. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

Nilufer Guleyupoglu, MD Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication About Nilufer Guleyupoglu, MD Dr. Guleyupoglu has over 25 years experience in the healthcare field. She is a Physician with Unique Pain Medicine, which is a national medical practice providing patient care targeting pain management. She is a Physiatrist who consults with nursing homes regarding pain management for rehabilitation patients. Dr. Guleyupoglu provides pain management services through her own practice. She assesses patients and provides pain management plans accordingly. She prescribes medication as needed. Dr. Guleyupoglu is affiliated with the A.A.P.N.M.R. and the A.B.P.M.R. Several of her articles have been published. Dr. Guleyupoglu utilizes a variety of pain treatment modalities to help patients relieve pain, optimize their functionality and enhance their quality of life. She is extremely thorough while treating patients and ensures they understand all their options. After obtaining her M.D. at Istanbul University Faculty of Medicine, Dr. Guleyupoglu completed her residency in physical medicine and rehabilitation at New York Medical and completed a Fellowship in pain medicine at Beth Israel Medical Center. Previously she served with the department of Pain Medicine and Palliative Care at Mount Sinai Beth Israel as an Attending Physician and was Assistant Professor with the Department of Physical Medicine and Rehabilitation at the Icahn School of Medicine and Albert Einstein College of Medicine. She contributed to the development of pain fellowship programs and has trained several generations of pain physicians for over 10 years. In her spare time, Dr. Guleyupoglu enjoys cooking and ballroom dancing. For further information, contact About Strathmore’s Who’s Who Worldwide Strathmore’s Who’s Who Worldwide highlights the professional lives of individuals from every significant field or industry including business, medicine, law, education, art, government and entertainment. Strathmore’s Who’s Who Worldwide is both an online and hard cover publication where we provide our members’ current and pertinent business information. It is also a biographical information source for thousands of researchers, journalists, librarians and executive search firms throughout the world. Our goal is to ensure that our members receive all of the networking, exposure and recognition capabilities to potentially increase their business. River Edge, NJ, April 28, 2017 --( PR.com )-- Nilufer Guleyupoglu, MD of River Edge, New Jersey has been recognized as a Professional Of The Year for 2017 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievement in the field of healthcare.About Nilufer Guleyupoglu, MDDr. Guleyupoglu has over 25 years experience in the healthcare field. She is a Physician with Unique Pain Medicine, which is a national medical practice providing patient care targeting pain management. She is a Physiatrist who consults with nursing homes regarding pain management for rehabilitation patients. Dr. Guleyupoglu provides pain management services through her own practice. She assesses patients and provides pain management plans accordingly. She prescribes medication as needed. Dr. Guleyupoglu is affiliated with the A.A.P.N.M.R. and the A.B.P.M.R. Several of her articles have been published.Dr. Guleyupoglu utilizes a variety of pain treatment modalities to help patients relieve pain, optimize their functionality and enhance their quality of life. She is extremely thorough while treating patients and ensures they understand all their options.After obtaining her M.D. at Istanbul University Faculty of Medicine, Dr. Guleyupoglu completed her residency in physical medicine and rehabilitation at New York Medical and completed a Fellowship in pain medicine at Beth Israel Medical Center. Previously she served with the department of Pain Medicine and Palliative Care at Mount Sinai Beth Israel as an Attending Physician and was Assistant Professor with the Department of Physical Medicine and Rehabilitation at the Icahn School of Medicine and Albert Einstein College of Medicine. She contributed to the development of pain fellowship programs and has trained several generations of pain physicians for over 10 years.In her spare time, Dr. Guleyupoglu enjoys cooking and ballroom dancing.For further information, contact www.uniquepainmedicine.com. About Strathmore’s Who’s Who WorldwideStrathmore’s Who’s Who Worldwide highlights the professional lives of individuals from every significant field or industry including business, medicine, law, education, art, government and entertainment. Strathmore’s Who’s Who Worldwide is both an online and hard cover publication where we provide our members’ current and pertinent business information. It is also a biographical information source for thousands of researchers, journalists, librarians and executive search firms throughout the world. Our goal is to ensure that our members receive all of the networking, exposure and recognition capabilities to potentially increase their business. Click here to view the list of recent Press Releases from Strathmore Worldwide


Patent
Istanbul University | Date: 2017-05-31

The present invention, is related to newly determined antiangiogenic effect of a palladium complex [Pd(sac)(terpy)] (sac)4H2O (sac=saccharinate and terpy=2,2:6,2-terpyridine)] apart from the antineoplastic effect. The present invention in another aspect, is related to use of the aforementioned Palladium complex in treatment of diseases in which angiogenesis is effective, especially in treatment of chronic inflammation, cardiovascular diseases and ocular diseases. More especially, the present invention is related to the use of the palladium complex according to this invention in treatment of the aforementioned diseases which are developed with angiogenesis.


The present invention is related to a nickel complex salt of formula (I) comprising S-methyl-isothiosemicarbazone, triphenylphosphine and isopropyl alcohol. Said nickel complex salt is prepared by the reaction of 5-Bromo-2-hydroxy-benzaldeyde-S-methly-isothiosemicarbazone with [Ni(PPh_(3))_(2)X_(2)] in the presence of isopropyl alcohol, wherein X is a halide. The current invention is further related to the use of the nickel complex salt 5-bromo-2-hydroxy-benzaldeyde-S-methly-isothiosemicarbazido triphenylphosphine nickel halide isopropyl alcohol as a volatile solid metallo-organic precursor in the CVD applications particularly for preparing thin metallic films of nickel.


Patent
Istanbul University, Aktas and Duran | Date: 2017-04-05

The present invention relates to a system which ensures damage assessment in marine vehicles and to a manufacturing method of this system. The system presented in the scope of the invention basically comprises a conductive composite layer comprising fibers exposed to a polymeric resin having electrically conductive nanoparticles, wherein at least an inner electrode is embedded into this layer; an insulating layer covering said surface layers is applied and also over this, an outer electrode is provided in an area wherein the marine vehicle is in contact with the water. Said inner and outer electrodes are connected to a power supply and therefore a continuous resistance measurement is made. There is also provided within the system a control unit measuring the resistance and generating an electrical signal in case of that said unit measures a resistance value below a predetermined threshold resistance value, and a warning means which converts the electrical signal generated by said control unit into a warning signal.


Patent
Istanbul University, Aktas and Duran | Date: 2017-02-08

The present invention is related to a leaf spring system allowing damage assessment in leaf springs (2) used in the motor vehicles and to a production method of the same. The system of the present invention particularly comprises a leaf spring (2) which comprises a series of fiber fabric layers exposed to polymeric resin with electrically conductive nanoparticles, therefore providing electrical conductivity with nanoparticle matrices along the entire fiber fabric layers; a current generator (6) in order for passage of electrical current throughout said leaf spring (2); a control unit (7) which is connected to both ends of said leaf spring (2) via conductors and measuring the resistance throughout the spring (2) and generating an electrical signal depending on the resistance or the current of the circuit; and a warning means in order to convert the electrical signal generated by said control unit (7) to a warning signal.


Onat A.,Istanbul University | Can G.,Istanbul University
Current Pharmaceutical Design | Year: 2014

Insight is provided herein into the novel mechanisms of cardiometabolic risk. Previous reports, including the epidemiological work of the Turkish Adult Risk Factor study, indicated that proinflammatory state and oxidative stress are crucial for evaluating cardiometabolic risk. Autoimmune pathways in the course of oxidative stress are major determinants of cardiorenal and metabolic risk. The latter encompasses metabolic syndrome, type 2 diabetes, coronary heart disease, and chronic kidney disease (CKD). Along with platelet-activating factor acetylhydrolase, creatinine, thyroid stimulating hormone, acylation-stimulating protein, asymmetric dimethylarginine, and serum lipoprotein[Lp](a) are triggers of systemic low-grade inflammation and enhanced autoimmune reactions. Related studies are analyzed in the current review. Lp(a) plays a crucial role by taking part in the immune activation, thereby accelerating the course of diabetes, CKD, and other chronic disorders. Populations prone to impaired glucose tolerance, and particularly peri- and postmenopausal women, are at high risk of developing related vascular complications. © 2014 Bentham Science Publishers.


Over the past decade, earthquakes proved to be the deadliest of all European disasters, with almost 19,000 fatalities and direct economic losses of approx. 29 billion. Earthquake Induced Liquefaction Disasters (EILDs) is responsible for tremendous amounts of the structural damages and fatalities; with experiences from recent events giving example of where approx. half of the economic loss was directly caused by liquefaction. Liquefaction is a phenomenon, with previously a low profile until recent earthquake events, in which the stiffness and strength of soil is reduced by seismic activity. With the causes of Liquefaction being known, it is important to recognize the factors that contribute to its occurrence; as well as the resulting hazards. The theory on how to address the subject has been comprehensive, as well as the engineering to reduce its consequences of liquefaction already developed; however, recent findings and advances need to be accurately examined in order to implement mitigation strategies practically. A systematic approach is needed for assessing the possibility of liquefaction on a site, prior to construction, then implementing the most appropriate liquefaction mitigation techniques. However, the variability of circumstances, invariably translates to multiple approaches of implementation, based on the susceptibility of the location to liquefaction, as well as the type and size of structure. The LIQUEFACT project addresses the mitigation of risks to EILD events in European communities with a holistic approach. The project not only deals with the resistance of structures to EILD events, but also, the resilience of the collective urban community in relation to their quick recovery from an occurrence. The LIQUEFACT project sets out to achieve a more comprehensive understanding of EILDs, the applications of the mitigation techniques, and the development of more appropriate techniques tailored to each specific scenario, for both Europe and global.


Grant
Agency: European Commission | Branch: H2020 | Program: CSA | Phase: ISSI-3-2015 | Award Amount: 3.00M | Year: 2016

The Marina proposal overall aim is to create an all-inclusive Knowledge Sharing Platform (KSP) catalysing and organising the convergence of already existing networks, communities, on-line platforms and services providing an online socio-technical environment that facilitates and stimulates the direct engagement of researchers, Civil Society Organisations (CSOs), citizens, industry stakeholders, policy and decision makers, research funders and communicators for improving Responsible Research and Innovation. In particular, the project will establish, curate and experiment a Responsible Research and Innovation platform involving societal actors working together during the whole research and innovation process for aligning better both the process and its outcomes, with the values, needs and expectations of European society, integrating citizens visions, needs and desires into science and innovation, promoting RRI with focus on marine issues and pressures that have important effects on the European societies. The project activities and outcomes, even if connected with marine research field, will define this systematic approach in order to make it transferable and reproducible for any RRI thematic domain. All project results and activities will be extrapolated from the RRI marine field to general RRI and broadly disseminated. The expected outcome of the Work Programme is a clear improvement of the integration of society in science and innovation. The MARINA project will follow this strategic line of strengthening and facilitating the capacity of the research and innovation to align and integrate the social needs through a suitable knowledge sharing platform and federating activities.


Noyan N.,Istanbul University
Computers and Operations Research | Year: 2012

Traditional two-stage stochastic programming is risk-neutral; that is, it considers the expectation as the preference criterion while comparing the random variables (e.g., total cost) to identify the best decisions. However, in the presence of variability risk measures should be incorporated into decision making problems in order to model its effects. In this study, we consider a risk-averse two-stage stochastic programming model, where we specify the conditional-value-at-risk (CVaR) as the risk measure. We construct two decomposition algorithms based on the generic Benders-decomposition approach to solve such problems. Both single-cut and multicut versions of the proposed decomposition algorithms are presented. We adapt the concepts of the value of perfect information (VPI) and the value of the stochastic solution (VSS) for the proposed risk-averse two-stage stochastic programming framework and define two stochastic measures on the VPI and VSS. We apply the proposed model to disaster management, which is one of the research fields that can significantly benefit from risk-averse two-stage stochastic programming models. In particular, we consider the problem of determining the response facility locations and the inventory levels of the relief supplies at each facility in the presence of uncertainty in demand and the damage level of the disaster network. We present numerical results to discuss how incorporating a risk measure affects the optimal solutions and demonstrate the computational effectiveness of the proposed methods. © 2011 Elsevier Ltd. All rights reserved.


Gul A.,Istanbul University
Current Opinion in Rheumatology | Year: 2014

PURPOSE OF REVIEW: Behçet's disease is a complex disease, and genetic susceptibility plays a critical role. This review aimed to discuss the recent genomewide association study (GWAS) findings and their implications to the pathogenesis of Behçet's disease. RECENT FINDINGS: GWAS data confirmed the major role of HLA-B51 in Behçet's disease susceptibility, and the discovery of epistatic interactions between HLA-B51 and ERAP1 variants provided some hints about its possible pathogenic mechanisms. Investigation of human leukocyte antigen (HLA) Class I region showed weaker but independent associations around HLA-A and HLA-C regions. Genomewide studies also established associations with IL10, IL23R, CCR1, STAT4, KLRC4, GIMAP2/GIMAP4, and UBAC2 genes in Behçet's disease patients of different ethnicities. Deep resequencing of targeted genes identified additional associations with rare variants in TLR4, MEFV, and NOD2 genes. SUMMARY: GWAS data established a major step forward by providing insights into the underlying mechanisms in Behçet's disease with the discovery of new susceptibility genes. These variations may implicate defects in the sensing and processing of microbial and endogenous danger signals as well as in the regulation of innate and adaptive immune responses in Behçet's disease. Association findings with HLA Class I antigens as well as IL23R, ERAP1, IL10, and MEFV genes also suggest shared inflammatory pathways with spondyloarthropathies. © 2013 Wolters Kluwer Health Lippincott Williams & Wilkins.

Loading Istanbul University collaborators
Loading Istanbul University collaborators